Chair: Dr Roger Henderson
Dr Roger Henderson is a senior GP, recently retired from his long-standing position as the head of a 16,000-patient general practice in Shropshire where he was also a GP trainer, running his large main surgery and two branch surgeries.
He now works as a sessional GP in order to concentrate on his health PR and media work. One of the UK’s most respected media medics, writing columns for national newspapers, magazines and blogs, he appears regularly on television, radio and the internet discussing health-related issues.
He chairs and speaks at many health conferences both in the UK and globally and is the UK Medical Director for LIVA Healthcare – winner of the Health IT firm of the year at the Health Investor Awards 2018 and also the Healthtech Innovators of the Year for Europe at the GHP Healthcare & Pharmaceutical Awards 2018. He is also a member of the steering committee of the Primary Care and Community Neurology Society that helps spearhead the development of community neurology services.
Dr Mark Glover
Mark trained in pre-clinical pharmacology and clinical medicine at Gonville and Caius College, Cambridge. His clinical and research interests are in hypertension and the identification of novel anti-hypertensive drug targets by understanding the molecular pathophysiology of sodium reabsorption in the distal nephron. He leads the hypertension clinic in Nottingham.
Mark’s current research is focussed on the molecular pathophysiology of sodium reabsorption via the thiazide-sensitive pathway, based on genetic analysis of individuals with the Mendelian Gordon syndrome and Thiazide-Induced Hyponatraemia in those with essential hypertension.
Mark’s other interests are in medical education and general (internal) medicine. He is a member of the Prescribing Safety Assessment Board for UK medical students, an associate member of the Higher Education Academy, a member of NICE Technology Appraisal Committee B, the NICE hypertension in adults guideline committee and the MHRA Pharmaco-vigilance committee.
Prof Ahmet Fuat
Professor Ahmet Fuat has been a GP in Darlington, Co.Durham for 33 years.He has been a GPSI Cardiology for 20 years having undertaken a Postgraduate Diploma in Cardiology at Bradford University graduating with distinction. He started the first one stop diagnostic and integrated heart failure clinic in the UK in 17 years ago with local colleagues.
His PhD by research in heart failure diagnosis and management including work on natriuretic peptides generated several publications that have informed guidelines and led to the award of an Honorary Professorial Chair at Durham University.
He holds various roles in CVD and research including the elected President of the new Primary Care Cardiovascular Society (PCCS) which he was instrumental in reforming, CVD Clinical Adviser to the RCGP, CVD and Research Leads for Darlington Primary Care Network (PCN) and Federation, Associate Lead for Industry Research at North East and North Cumbria NIHR CRN. He is a Governing Body member and Chair of the newly formed Darlington PCN.
He has a passion for medical education and remains an active lecturer, tutor and researcher. He is on the editorial boards of the British Journal of Cardiology and Primary Care Cardiovascular Journals and a peer reviewer for most high impact Cardiovascular journals and research bodies. His work in community cardiology has been recognised with Fellowships from the RCGP, RCP London and RCP Edinburgh.
Dr Jim Moore
Dr Jim Moore studied medicine in Edinburgh before moving to Gloucestershire to work as a GP principal. He has an interest in cardiology and cardiovascular disease, particularly those aspects that are relevant to primary care. He was involved in the development of the Primary care based Gloucestershire Heart Failure service where he presently work as a GPwSI.
Dr Moore continues to represent primary care in the cardiovascular arena at both a local and regional network level. He presently sits on the committee reviewing the NICE Chronic Heart Failure Guideline and is a member of the National Heart Failure Audit Steering group. He has previously served on the board of the British Society for Heart Failure.